Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Charles T. Gordon is active.

Publication


Featured researches published by Charles T. Gordon.


Journal of Clinical and Experimental Neuropsychology | 1993

Dysfunctional attention in autistic savants

B. J. Casey; Charles T. Gordon; Glenn Mannheim; Judith M. Rumsey

A dysfunctional attention hypothesis of the basis of savant skills was tested with a series of computerized tasks that assessed the ability to divide, shift, direct, and sustain attention. Ten healthy men with pervasive developmental disorders and unusual calendar-calculating skill, and 10 age- and sex-matched controls were tested. There were four general findings. First, the savants and controls did not differ on a measure of visual sustained attention. Second, the savants failed to detect rare auditory targets significantly more than did the controls. Third, the savants were unable to efficiently divide their attention when required to detect both visual and auditory targets simultaneously. Finally, deficient orienting or a deficit in shifting selective attention from one stimulus location to another was evidenced in overall slower reaction times for the savants across tasks requiring shifts and redirecting of attention. This deficit was attributed to an inability to disengage attention as a result of deficient orienting and overselectivity.


Journal of the American Academy of Child and Adolescent Psychiatry | 1994

An Open Trial of Clozapine in 11 Adolescents with Childhood-Onset Schizophrenia

Jean A. Frazier; Charles T. Gordon; Kathleen McKenna; Marge Lenane; Debbie Jih; Judith L. Rapoport

OBJECTIVE To review the response of 11 adolescents with childhood-onset schizophrenia to a 6-week open clozapine trial. METHOD Eleven children meeting DSM-III-R criteria for schizophrenia had a 6-week open trial of clozapine (mean sixth week daily dose 370 mg). Behavioral ratings included the Brief Psychiatric Rating Scale and Childrens Global Assessment Scale. RESULTS More than half showed marked improvement in Brief Psychiatric Rating Scale ratings by 6 weeks of clozapine therapy compared to admission drug rating and compared to a systematic 6-week trial of haloperidol. CONCLUSIONS This open trial indicates that clozapine may be a promising treatment for children and adolescents with schizophrenia who do not respond well to typical neuroleptics. A double-blind placebo-controlled study is ongoing.


Biological Psychiatry | 1996

Smooth pursuit eye movements in childhood-onset schizophrenia: Comparison with attention-deficit hyperactivity disorder and normal controls

Leslie K. Jacobsen; Walter L. Hong; Daniel W. Hommer; Susan D. Hamburger; F. Xavier Castellanos; Jean A. Frazier; Jay N. Giedd; Charles T. Gordon; Barbara I. Karp; Kathleen McKenna; Judith L. Rapoport

Abnormalities of the smooth pursuit eye movements of adults with schizophrenia have been well described. We examined smooth pursuit eye movements in schizophrenic children, contrasting them with normal and attention-deficit hyperactivity disorder (ADHD) subjects, to determine whether there is continuity of eye movement dysfunction between childhood- and adult-onset forms of schizophrenia. Seventeen schizophrenic children with onset of illness by age 12, 18 ADHD children, and 22 normal children were studied while engaged in a smooth pursuit eye tracking task. Eye tracking variables were compared across the three groups. Schizophrenic children exhibited significantly greater smooth pursuit impairments than either normal or ADHD subjects. Within the schizophrenic group, there were no significant relationships between eye tracking variables and clinical variables, or ventricular/brain ratio. Childhood-onset schizophrenia is associated with a similar pattern of smooth pursuit abnormalities to that seen in later-onset schizophrenia.


Psychiatry Research-neuroimaging | 1997

Cerebral glucose metabolism in childhood onset schizophrenia

Leslie K. Jacobsen; Susan D. Hamburger; John D. Van Horn; A. Catherine Vaituzis; Kathleen McKenna; Jean A. Frazier; Charles T. Gordon; Marge Lenane; Judith L. Rapoport; Alan J. Zametkin

Decreased frontal cortical glucose metabolism has been demonstrated in adult schizophrenics both at rest and while engaging in tasks that normally increase frontal metabolism, such as the Continuous Performance Test (CPT). The authors tested the hypothesis that adolescents with childhood onset schizophrenia would also demonstrate hypofrontality while performing the CPT. Cerebral glucose metabolism was examined in 16 adolescents (mean age 14.1 +/- 1.7) with onset of schizophrenia by age 12 (mean age at onset 9.9 +/- 1.8) and 26 healthy adolescents selected to be similar in age, sex and handedness using positron emission tomography and 18F-fluorodeoxyglucose. Patients with childhood onset schizophrenia made fewer correct and more incorrect identifications on the CPT. Region of interest analysis revealed no significant group differences in global cerebral glucose metabolism, but increased metabolic rate in supramarginal gyrus (F = 6.74, P < 0.05) and inferior frontal gyrus/insula (F = 7.09, P < 0.05) and decreased metabolic rate in middle frontal gyrus (F = 6.72, P < 0.05) and superior frontal gyrus (t = 2.04, P < 0.05) in schizophrenics. Comparison of effect sizes with an identically designed study of adult schizophrenics did not indicate more severe hypofrontality in childhood onset schizophrenia. Pixel-based analyses indicated a more complex pattern of group differences in cerebral metabolism with bilaterally increased cerebellar metabolic rate in childhood onset schizophrenics. These findings suggest that childhood onset schizophrenia may be associated with a similar, but not more severe, degree of hypofrontality relative to that seen in adult onset schizophrenia.


Journal of Autism and Developmental Disorders | 2000

Commentary: Considerations on the Pharmacological Treatment of Compulsions and Stereotypies with Serotonin Reuptake Inhibitors in Pervasive Developmental Disorders

Charles T. Gordon

Repetitive or ritualized behaviors have been considered an integral part of autistic disorder since Kanner’s original description in 1943. Presently 5 of the 13 DSM-IV criteria refer to stereotyped, repetitive, or ritualized behavior patterns of different types. Repetitive nonpurposeful motor behaviors of both involuntary (tics) and voluntary (motor stereotypies) nature are very frequently present. A desire for “sameness” and inflexible adherence to routines is combined with internal discomfort if such rituals are not closely followed in nearly all patients. Perseveration in terms of langugage use and interests is uniformly present. Finally, more typical obsessive-compulsive behaviors such as collecting, counting, and washing rituals are also frequently present. Strict and inflexible adherence to self-directed, repetitive patters of thinking and behaving and the tension, tantruming, and aggression which occur when one attempts to interfere with them impose major obstacles to learning and social development in autism. The relationship between these different types of repetitive behavior on a neurophysiological level is unclear. Nonselective and selective serotonin reuptake inhibitors and dopamine blockers (typical and atypical neuroleptic agents) have been the two classes of medications most helpful for reducing the impact of some of these behaviors on academic and social functioning. This discussion is focused on the serotonin reuptake blockers since neuroleptics are discussed elsewhere. The nonselective serotonin reuptake inhibitor, clomipramine, was shown to be differentially effective in treating autistic symptomatology with both placebo and the primarily noradrenergic tricyclic agent desipramine in a double-blind comparison in 24 children with autism and adolescents (Gordon, State, Nelson, Hamburger, & Rapoport, 1993). Clomipramine improved obsessive-compulsive symptoms as hypothesized.


Biological Psychiatry | 1995

Childhood-onset schizophrenia: The severity of premorbid course

J. Alaghband-Rad; Kathleen McKenna; Charles T. Gordon

OBJECTIVE To review the premorbid histories of 23 children meeting DSM-III-R criteria for schizophrenia with onset before age 12 years and to compare these with childhood data of later-onset schizophrenics. METHOD Premorbid features up to 1 year before onset of first psychotic symptoms were rated from hospital and clinic records, clinical interviews, rating scales, and tests. RESULTS In keeping with previous studies, specific developmental disabilities and transient early symptoms of autism, particularly motor stereotypies, were common. Comparison with the childhood of later-onset schizophrenics showed greater delay in language development, and more premorbid speech and language disorders, learning disorders, and disruptive behavior disorders. (Sixty percent had received or were estimated to meet criteria for one or more clinical diagnoses.) CONCLUSIONS Childhood-onset schizophrenia may represent a more malignant form of the disorder, although selection and ascertainment bias cannot be ruled out. The presence of prepsychotic language difficulties focuses attention on the importance of early temporal and frontal lobe development; early transient motor stereotypies suggest developmental basal ganglia abnormalities and extend previous findings seen in the childhood of later-onset patients.


Archives of General Psychiatry | 1993

A Double-blind Comparison of Clomipramine, Desipramine, and Placebo in the Treatment of Autistic Disorder

Charles T. Gordon; Rosanne C. State; Jean Nelson; Susan D. Hamburger; Judith L. Rapoport


Archives of General Psychiatry | 1996

Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison

Sanjiv Kumra; Jean A. Frazier; Leslie K. Jacobsen; Kathleen McKenna; Charles T. Gordon; Marge Lenane; Susan D. Hamburger; Amy Smith; Kathleen E. Albus; Javad Alaghband-Rad; Judith L. Rapoport


Journal of the American Academy of Child and Adolescent Psychiatry | 1994

Looking for childhood-onset schizophrenia : The first 71 cases screened

Kathleen McKenna; Charles T. Gordon; Marge Lenane; Debra Kaysen; Kimberly Fahey; Judith L. Rapoport


Archives of General Psychiatry | 1996

Brain Anatomic Magnetic Resonance Imaging in Childhood-Onset Schizophrenia

Jean A. Frazier; Jay N. Giedd; Susan D. Hamburger; Kathleen E. Albus; Debra Kaysen; A. Catherine Vaituzis; Jagath C. Rajapakse; Marge Lenane; Kathleen McKenna; Leslie K. Jacobsen; Charles T. Gordon; Alan Breier; Judith L. Rapoport

Collaboration


Dive into the Charles T. Gordon's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Judith L. Rapoport

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jean A. Frazier

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar

Susan D. Hamburger

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marge Lenane

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

J.L. Rapoport

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Jay N. Giedd

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Debra Kaysen

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Sanjiv Kumra

University of Minnesota

View shared research outputs
Researchain Logo
Decentralizing Knowledge